In multiple sclerosis, the upregulation of CXCL1 was induced by proinflammatory cytokines such as IL-1 beta and IFN-gamma [32] and those cytokines were also increased in a streptozotocin-induced diabetic neuropathy model [7, 28]. Here, CXCL1 is linked to diabetic neuropathy.